Table of Contents
Executive SummaryES-1
i. In vitro molecular diagnostics marketES-1
a. Selected market drivers and limitersES-4
b. Technology trends ES-4
c. Market leadersES-4
ii. Methodology ES-6

Exhibit ES-1: Molecular diagnostics products, combined market forecast ($m), by region, 2019-24 ES-2
Exhibit ES-2: Molecular diagnostics products, combined market forecast ($m), by product segment, 2019-24 ES-3

1. Molecular Diagnostics Clinical Overview1-1
1.1 Molecular diagnostics for infectious disease testing 1-1
1.1.1 Hepatitis B virus 1-3
1.1.2 Hepatitis C virus 1-3
1.1.3 Human immunodeficiency virus 1-3
1.1.4 Tuberculosis 1-4
1.1.5 Chlamydia trachomatis/Neisseria gonorrhoea 1-4
1.1.6 Human papillomavirus 1-6
1.1.7 Methicillin-resistant Staphylococcus aureus 1-7
1.1.8 Novel coronavirus (COVID-19) 1-7
1.1.9 Other infectious diseases 1-9
1.2 Molecular diagnostics for oncology testing 1-10
1.2.1 Prostate cancer 1-14
1.2.2 Breast cancer 1-14
1.2.3 Colorectal cancer 1-15
1.2.4 Other cancers 1-15
1.3 Molecular diagnostics for genetic testing 1-17
1.4 Molecular diagnostics for blood screening 1-20
1.5 Molecular diagnostics for other applications 1-21
1.5.1 Cardiovascular disease 1-22
1.5.2 Diabetes 1-23
1.5.3 Other applications 1-24
1.6 Bibliography 1-26

Exhibit 1-1: Epidemiology of selected infectious diseases, by region 1-5
Exhibit 1-2: Daily SARS-CoV-2 molecular test volume in the US 1-9
Exhibit 1-3: Incidence of selected cancer types, by region, 2018 1-12
Exhibit 1-4: Incidence of selected cancer types, by region, 2040 1-13
Exhibit 1-5: Epidemiology of selected genetic diseases, by region 1-18
Exhibit 1-6: Blood collection trends (‘000), by region, 2011-17 1-21
Exhibit 1-7: Cardiovascular disease mortality (‘000), by region, 2011-16 1-22
Exhibit 1-8: Prevalence of diabetes (‘000), by region, 2010-45 1-23
Exhibit 1-9: Organ transplantation procedures, by region, 2014-18 1-25

2. Molecular Diagnostics Products2-1
2.1 Technology insights 2-1
2.1.1 Polymerase chain reaction 2-1
2.1.2 Hybridization 2-2
2.1.3 Next-generation sequencing 2-2
2.1.4 Microarray technologies 2-3
2.1.5 Other technologies 2-3
2.2 Molecular diagnostics products for infectious disease testing 2-5
2.3 Molecular diagnostics products for oncology testing 2-7
2.4 Molecular diagnostics products for genetic testing 2-12
2.5 Molecular diagnostics products for blood screening 2-15
2.6 Molecular diagnostics products for other applications 2-16
2.7 Bibliography 2-18

Exhibit 2-1: Selected molecular diagnostics products for infectious disease testing, 2020 2-5
Exhibit 2-2: Selected molecular diagnostic products for oncology testing, 2020 2-9
Exhibit 2-3: Selected molecular diagnostics products for genetic testing, 2020 2-13
Exhibit 2-4: Selected molecular diagnostics products for blood screening, 2020 2-15
Exhibit 2-5: Selected molecular diagnostics products for other applications, 2020 2-16

3. Molecular Diagnostics Market3-1
3.1 Regional insights 3-1
3.1.1 US 3-1
3.1.2 Five major European markets 3-3
3.1.3 Japan 3-3
3.1.4 Rest of World 3-3
3.2 Molecular diagnostics, market forecast by product segment 3-4
3.2.1 Competitive analysis 3-6
3.3 Trends in the molecular diagnostics products market 3-8
3.3.1 Reimbursement/economic 3-8
3.3.2 Laboratory-developed tests 3-8
3.4 Market drivers and limiters 3-10
3.5 Molecular diagnostic products for infectious disease testing, market analysis 3-10
3.5.1 Competitive analysis 3-13
3.6 Molecular diagnostics for oncology testing, market analysis 3-14
3.6.1 Competitive analysis 3-16
3.7 Molecular diagnostics for genetic testing, market analysis 3-17
3.7.1 Competitive analysis 3-20
3.8 Molecular diagnostics for blood screening, market analysis 3-21
3.8.1 Competitive analysis 3-23
3.9 Molecular diagnostics for other applications, market analysis 3-24
3.9.1 Competitive analysis 3-27
3.10 Bibliography 3-28

Exhibit 3-1: Molecular diagnostics products, combined market forecast ($m), by region, 2019-24 3-2
Exhibit 3-2: Molecular diagnostics products, combined market forecast ($m), by segment, 2019-24 3-5
Exhibit 3-3: Molecular diagnostics products, combined market, global share by supplier, 2019 3-7
Exhibit 3-4: Molecular testing services/LDT market ($m), 2017-19 3-9
Exhibit 3-5: Molecular diagnostics products for infectious disease testing, market forecast ($m), by geographic region, 2019-24 3-12
Exhibit 3-6: Molecular diagnostics products for infectious disease testing, global share by supplier, 2019 3-14
Exhibit 3-7: Molecular diagnostics products for oncology testing, market forecast ($m), by region, 2019-24 3-15
Exhibit 3-8: Molecular diagnostics products market for oncology testing, share by supplier, 2019 3-17
Exhibit 3-9: Molecular diagnostics products for genetic testing, market forecast ($m), by region, 2019-24 3-19
Exhibit 3-10: Molecular diagnostics products for genetic testing, global share by supplier, 2019 3-20
Exhibit 3-11: Molecular diagnostics products for blood screening, market forecast ($m), by region, 2019-24 3-22
Exhibit 3-12: Molecular diagnostics products for blood screening, global share by supplier, 2019 3-23
Exhibit 3-13: Molecular diagnostics products for other applications, market forecast ($m), by region, 2019-24 3-26
Exhibit 3-14: Molecular diagnostics products for other applications, share by supplier, 2019 3-27

APPENDIX: COMPANY LISTING A-1